GlassScriptPhysician profile
Serena Spaleny
NPI 1255969226
$1,413.35
in general payments reported to CMS, 2019-2025
16 companies · $967 in 2025
The $967 reported for 2025 was more than what 81% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $104 · 2024: $342 · 2025: $967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.10 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $162.30 | 2024-2025 | Spravato |
| Neurocrine Biosciences, INC. | $134.14 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $126.34 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $104.06 | 2024-2025 | Rexulti |
| Sage Therapeutics, LLC | $103.83 | 2022 | |
| Janssen Scientific Affairs, LLC | $86.87 | 2025 | Spravato |
| Alkermes, INC. | $84.07 | 2024-2025 | Lybalvi |
| Almatica Pharma LLC | $68.91 | 2024-2025 | Loreev Xr |
| Vanda Pharmaceuticals INC. | $68.43 | 2025 | Fanapt |
| Tempus Ai, INC | $56.00 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.85 | 2024-2025 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $41.29 | 2024-2025 | Austedo Xr, Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $33.55 | 2025 | Cobenfy |
| Bausch Health US, LLC | $18.59 | 2024 | Aplenzin |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $12.02 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Serena Spaleny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.